GBIO - Generation Bio Co.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
96,718
96,718
85,247
58,532
50,134
Selling General and Administrative
44,464
44,464
33,854
22,582
12,168
Total Operating Expenses
141,182
141,182
119,101
81,114
62,302
Operating Income or Loss
-141,182
-141,182
-119,101
-81,114
-62,302
Interest Expense
-
-
50
-
-
Income Before Tax
-136,639
-136,639
-119,151
-80,523
-61,317
Income from Continuing Operations
-136,639
-136,639
-119,151
-80,523
-61,317
Net Income
-136,639
-136,639
-119,151
-80,523
-61,317
Net Income available to common shareholders
-136,639
-136,639
-119,151
-80,523
-61,317
Basic EPS
-
-
-2.12
-2.95
-1.95
Diluted EPS
-
-
-2.12
-2.95
-1.95
Basic Average Shares
-
-
56,295
27,256
31,389
Diluted Average Shares
-
-
56,295
27,256
31,389
EBITDA
-
-141,182
-119,101
-81,114
-60,438